About
Estuardo Aguilar-Cordova is the Founder and CSO Candel Therapeutics. He has more than 30 years of experience in the fields of biotherapeutics, cancer research and drug development, including serving as principal or co-investigator in more than 25 clinical trials ranging from Phase I to Phase III. Prior to moving into his role at Candel, Estuardo Aguilar-Cordova held academic positions for nearly two decades. Most recently, he was deputy director of the Harvard Gene Therapy Initiative at Harvard Medical School in Boston and was a faculty member in Pediatrics, Hematology-Oncology at Baylor College of Medicine in Houston. He has served on many national oversight committees, including roles as chairman and member of the NIH Recombinant Advisory Committee (RAC), as a consultant to the FDA Biological Response Modifiers Advisory Committee (BRMAC), and as a member of the Vaccine and Related Products Advisory Committee (VRPAC). Estuardo Aguilar-Cordova has also held other appointments includi
Position in the VCSift Database
- • 2 investors at Candel Therapeutics are tracked.
- • 3 investors hold the Founder and CSO role in VCSift. Estuardo Aguilar-Cordova is one of them.
- • 4 investors are based in Auburndale, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Auburndale, US
Contact Information
Find more investors like Estuardo
Search Investors